vs
Burke & Herbert Financial Services Corp.（BHRB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Burke & Herbert Financial Services Corp.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$86.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 4.9%），Burke & Herbert Financial Services Corp.自由现金流更多（$96.2M vs $14.4M），过去两年Burke & Herbert Financial Services Corp.的营收复合增速更高（81.1% vs 31.3%）
伯克赫伯特金融服务公司是美国区域型金融控股企业，主营个人与商业银行业务、财富管理、住房抵押贷款、小微企业融资服务，核心市场覆盖弗吉尼亚州及大西洋沿岸中部邻近区域，服务零售客户、中小企业及高净值人群。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
BHRB vs PBYI — 直观对比
营收规模更大
BHRB
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出22.8%
4.9%
自由现金流更多
BHRB
多$81.8M
$14.4M
两年增速更快
BHRB
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.5M | $75.5M |
| 净利润 | $30.2M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 43.8% | 22.7% |
| 净利率 | 34.9% | — |
| 营收同比 | 4.9% | 27.7% |
| 净利润同比 | 52.8% | — |
| 每股收益（稀释后） | $1.98 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BHRBPBYI
| Q4 25 | $86.5M | $75.5M | ||
| Q3 25 | $85.4M | $54.5M | ||
| Q2 25 | $87.1M | $52.4M | ||
| Q1 25 | $83.0M | $46.0M | ||
| Q4 24 | $82.5M | $59.1M | ||
| Q3 24 | $83.8M | $80.5M | ||
| Q2 24 | $69.3M | $47.1M | ||
| Q1 24 | $26.4M | $43.8M |
净利润BHRBPBYI
| Q4 25 | $30.2M | — | ||
| Q3 25 | $30.0M | $8.8M | ||
| Q2 25 | $29.9M | $5.9M | ||
| Q1 25 | $27.2M | $3.0M | ||
| Q4 24 | $19.8M | — | ||
| Q3 24 | $27.6M | $20.3M | ||
| Q2 24 | $-16.9M | $-4.5M | ||
| Q1 24 | $5.2M | $-4.8M |
毛利率BHRBPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率BHRBPBYI
| Q4 25 | 43.8% | 22.7% | ||
| Q3 25 | 43.3% | 17.6% | ||
| Q2 25 | 42.7% | 12.7% | ||
| Q1 25 | 39.6% | 8.7% | ||
| Q4 24 | 24.6% | 22.6% | ||
| Q3 24 | 39.2% | 27.4% | ||
| Q2 24 | -27.5% | -4.6% | ||
| Q1 24 | 22.3% | -5.3% |
净利率BHRBPBYI
| Q4 25 | 34.9% | — | ||
| Q3 25 | 35.1% | 16.2% | ||
| Q2 25 | 34.3% | 11.2% | ||
| Q1 25 | 32.8% | 6.5% | ||
| Q4 24 | 24.0% | — | ||
| Q3 24 | 33.0% | 25.2% | ||
| Q2 24 | -24.4% | -9.6% | ||
| Q1 24 | 19.8% | -11.0% |
每股收益（稀释后）BHRBPBYI
| Q4 25 | $1.98 | $0.26 | ||
| Q3 25 | $1.97 | $0.17 | ||
| Q2 25 | $1.97 | $0.12 | ||
| Q1 25 | $1.80 | $0.06 | ||
| Q4 24 | $1.72 | $0.40 | ||
| Q3 24 | $1.82 | $0.41 | ||
| Q2 24 | $-1.41 | $-0.09 | ||
| Q1 24 | $0.69 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $854.6M | $130.3M |
| 总资产 | $7.9B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资BHRBPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务BHRBPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益BHRBPBYI
| Q4 25 | $854.6M | $130.3M | ||
| Q3 25 | $822.2M | $115.3M | ||
| Q2 25 | $780.0M | $104.7M | ||
| Q1 25 | $758.0M | $97.1M | ||
| Q4 24 | $730.2M | $92.1M | ||
| Q3 24 | $738.1M | $71.1M | ||
| Q2 24 | $693.1M | $48.5M | ||
| Q1 24 | $319.3M | $51.0M |
总资产BHRBPBYI
| Q4 25 | $7.9B | $216.3M | ||
| Q3 25 | $7.9B | $202.9M | ||
| Q2 25 | $8.1B | $194.9M | ||
| Q1 25 | $7.8B | $196.2M | ||
| Q4 24 | $7.8B | $213.3M | ||
| Q3 24 | $7.9B | $220.7M | ||
| Q2 24 | $7.8B | $205.0M | ||
| Q1 24 | $3.7B | $214.1M |
负债/权益比BHRBPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $107.9M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $96.2M | $14.4M |
| 自由现金流率自由现金流/营收 | 111.2% | 19.1% |
| 资本支出强度资本支出/营收 | 13.5% | 0.0% |
| 现金转化率经营现金流/净利润 | 3.57× | — |
| 过去12个月自由现金流最近4个季度 | $164.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流BHRBPBYI
| Q4 25 | $107.9M | $14.4M | ||
| Q3 25 | $39.3M | $9.7M | ||
| Q2 25 | $41.0K | $14.1M | ||
| Q1 25 | $37.6M | $3.6M | ||
| Q4 24 | $85.8M | $15.6M | ||
| Q3 24 | $47.8M | $11.0M | ||
| Q2 24 | $-46.0M | $1.0M | ||
| Q1 24 | $7.1M | $11.2M |
自由现金流BHRBPBYI
| Q4 25 | $96.2M | $14.4M | ||
| Q3 25 | $35.4M | $9.7M | ||
| Q2 25 | $-3.4M | $14.1M | ||
| Q1 25 | $35.9M | $3.6M | ||
| Q4 24 | $81.2M | $15.6M | ||
| Q3 24 | $46.0M | $11.0M | ||
| Q2 24 | $-47.0M | $1.0M | ||
| Q1 24 | $5.6M | — |
自由现金流率BHRBPBYI
| Q4 25 | 111.2% | 19.1% | ||
| Q3 25 | 41.5% | 17.7% | ||
| Q2 25 | -3.9% | 26.8% | ||
| Q1 25 | 43.2% | 7.7% | ||
| Q4 24 | 98.5% | 26.4% | ||
| Q3 24 | 55.0% | 13.7% | ||
| Q2 24 | -67.8% | 2.1% | ||
| Q1 24 | 21.2% | — |
资本支出强度BHRBPBYI
| Q4 25 | 13.5% | 0.0% | ||
| Q3 25 | 4.5% | 0.0% | ||
| Q2 25 | 3.9% | 0.0% | ||
| Q1 25 | 2.1% | 0.1% | ||
| Q4 24 | 5.5% | 0.0% | ||
| Q3 24 | 2.1% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 5.7% | 0.0% |
现金转化率BHRBPBYI
| Q4 25 | 3.57× | — | ||
| Q3 25 | 1.31× | 1.10× | ||
| Q2 25 | 0.00× | 2.41× | ||
| Q1 25 | 1.38× | 1.21× | ||
| Q4 24 | 4.33× | — | ||
| Q3 24 | 1.73× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.36× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
